With record-breaking investment, faster regulatory pathways, and stronger returns, the US has become the next strategic move for many European life sciences companies. But success in this market isn’t just about timing - it’s about understanding what’s different and planning accordingly. This guide breaks down the opportunities, challenges, and critical factors behind a successful US expansion strategy in 2025.
Understand how healthcare spending, talent access, and regulatory frameworks differ between the EU and the US so you can position your strategy with a global perspective.
